Text Size

Cognitive Behavioral Therapy for Trichotillomania (CBT for TTM)

This study has been completed.
Sponsor:
Collaborator:
Emory University
Information provided by (Responsible Party):
Nancy J. Keuthen, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00740909
First received: August 21, 2008
Last updated: June 19, 2012
Last verified: June 2012
History of Changes
  Purpose

This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condition. We hypothesize that outcome at post-treatment, 3-month, and 6-month follow-up will be better for the CBT vs. MAC condition including higher responder rates and greater reduction in hair pulling severity.


Condition Intervention Phase
Trichotillomania
 Behavioral: Cognitive Behavioral Therapy
 Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Cognitive Behavioral Therapy for Trichotillomania

Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • Massachusetts General Hospital Hair Pulling Scale (MGHHPS) [ Time Frame: Baseline, weekly visits, follow-up ] [ Designated as safety issue: No ]
  • NIMH Trichotillomania Severity Scale (NIMH-TSS) [ Time Frame: Baseline, weekly visits, follow-up ] [ Designated as safety issue: No ]
  • NIMH Trichotillomania Impairment Scale (NIMH-TIS) [ Time Frame: Baseline, weekly visits, follow-up ] [ Designated as safety issue: No ]

Enrollment: 38
Study Start Date: November 2008
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: MAC
Minimal Attention Control
Experimental: CBT
Cognitive Behavioral Therapy
 Behavioral: Cognitive Behavioral Therapy
A therapy designed to help patients with response prevention skills.

Detailed Description:

The purpose of this study is to assess the efficacy of cognitive behavioral therapy for patients with trichotillomania.

Following entry into the study, subjects will be randomized into a cognitive behavioral therapy (CBT) or a minimized attention control (MAC) condition. Subjects will be assessed with the Acceptance and Action Questionnaire (AAQ), the Affective Regulation Rating (ARR), the Barratt Impulsivity Scale (BIS-11), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Clinical Global Impressions Scale (CGI), the Difficulties in Emotion Regulation Scale (DERS), Hair Pulling Scale (HPS), Trichotillomania (TTM) Impact Scale, Psychiatric Institute Trichotillomania Scale (PITS), National Institute of Mental Health Trichotillomania Severity Scale(NIMH-TSS), the Generalized Expectancy for Negative Mood Regulation Scale (NMR), The Milwaukee Inventory for Subtypes of Trichotillomania- Adult Version (MIST-A), the Positive and Negative Affect Scale (PANAS), the Quality of Life Inventory (QOLI), the Readiness to Change Hairpulling Behavior (RCHPB), the Self-Esteem Scale (SES), the Skin Picking Scale (SPS) and the Scales of Psychological Well-Being (SPWB). Subject randomization to a treatment arm will be determined by a random number generator.

Subject change scores will be assessed for the above scales.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • primary DSM-IV diagnosis of TTM
  • outpatients who are 18 or older
  • a minimum MGHHPS total scale score of 10
  • a minimum TTM symptom duration of 1 year with no significant remissions (as defined by complete abstinence of hair extraction for a 2-week period during the prior 6 months)

Exclusion Criteria:

  • presence of a serious psychiatric condition including mental retardation, psychosis, pervasive developmental disorder, organic mental disorders, manic episode, ADHD, suicidality, lifetime alcohol or substance dependence, or alcohol or substance abuse within the past 3 months
  • presence of a serious medical condition that would limit ability to routinely attend sessions and complete homework assignments
  • individual or group psychotherapy (not addressing TTM) that has not been ongoing for the past 3 months and/or without intent to continue same treatment during study tenure)
  • previous CBT for TTM
  • involvement in other treatment for TTM
  • psychotropic medication that has not been stable for 3 months prior to study enrollment and/or without intent to continue same medication regimen during study tenure)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00740909

Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
Emory University
Investigators
Principal Investigator: Nancy Keuthen, PhD Massachusetts General Hospital
  More Information

No publications provided by Massachusetts General Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Nancy J. Keuthen, Nancy J. Keuthen, Ph.D, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00740909     History of Changes
Other Study ID Numbers: 2008P000565
Study First Received: August 21, 2008
Last Updated: June 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
Trich
Hair Pulling
Cognitive Behavioral Therapy
Behavioral Therapy

Additional relevant MeSH terms:
Trichotillomania
Impulse Control Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 21, 2013